Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

Marlies S. Wijsenbeek, Francesco Bonella, Leticia Orsatti, Anne-Marie Russell, Claudia Valenzuela, Wim A. Wuyts, Walter F. Baile

Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marlies S. Wijsenbeek, Francesco Bonella, Leticia Orsatti, Anne-Marie Russell, Claudia Valenzuela, Wim A. Wuyts, Walter F. Baile. Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?. ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe idiopathic pulmonary fibrosis: what can be done?
Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017
Year: 2017



The therapy of idiopathic pulmonary fibrosis: what is next?
Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019
Year: 2019



Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Towards a better diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 108-113
Year: 2011



Idiopathic pulmonary fibrosis: time for greater expectations?
Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018
Year: 2018



Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003


Exercise training in idiopathic pulmonary fibrosis: is it of benefit?
Source: Breathe 2016; 12: 130-138
Year: 2016



Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016

Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005

Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: Comparison with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013

Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Approach to diagnosis of idiopathic pulmonary fibrosis
Source: International Congress 2016 – Russia Session
Year: 2016

Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient
Source: Eur Respir J 2016; 47: 1057-1059
Year: 2016


Pirfenidone in patients with advanced idiopathic pulmonary fibrosis: First experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis?
Source: Eur Respir J 2013; 41: 250-251
Year: 2013


Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation
Source: Eur Respir J 2012; 40: 794-795
Year: 2012